Position in COLL
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$2,602,707
+$1,122,064 QoQ
Shares Held
71,898
+60.6% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 277 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $96,211,937 across 30 Drug Manufacturers - Specialty & Generic names. COLL ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
503,917 | $36,211,475 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
348,043 | $8,565,338 | |
| 3 | VTRS |
Viatris Inc
|
532,076 | $8,449,366 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
15,582 | $8,442,795 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
46,762 | $7,881,267 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
211,326 | $3,062,113 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
This page
|
71,898 | $2,602,707 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
147,185 | $2,547,772 |
All Filings in COLL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,602,707 | 71,898 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,480,643 | 44,773 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $364,195 | 7,866 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $245,209 | 7,008 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||